CEO: | Adrian Kinkaid |
Chairman: | Simon Gordon Douglas |
Chief Scientific Officer: | Richard John Buick |
Non-Executive Dir: | Matthew Baker, Colin Walsh |
Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
Website: | https://www.fusionantibodies.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BDQZGK16 |
Currency | UK Pounds |
Share Price | 17.75p |
Change Today | 3.75p |
% Change | 26.79 % |
52 Week High | 19.00 |
52 Week Low | 3.25 |
Volume | 3,335,368 |
Shares Issued | 113.66m |
Market Cap | £20.17m |
Beta | 0.02 |
RiskGrade | 464 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
12:20 | 5,000 @ 18.29p |
12:13 | 7,131 @ 18.30p |
12:12 | 2,000 @ 17.63p |
12:10 | 21,830 @ 18.30p |
11:05 | 66,824 @ 17.86p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research